A Safety and Efficacy Study of One-time SAR402663 in Adults With Neovascular Age-related Macular Degeneration

NCT06660667 · clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
RECRUITING
Status
66
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Sanofi